Vivos Therapeutics reports $3.9M in Q1 revenue: 5 notes

Medical technology company Vivos Therapeutics brought in $3.9 million in first quarter revenue. 

Advertisement

The company released its first quarter financial report June 8. 

Here are five notes on the company’s first-quarter financial performance: 

1. Vivos’ earned more in the first quarter of this year compared to the $3.6 million it made during the first quarter of 2022. The company attributed this to higher provider enrollments and increased revenue from its seminars.

2. The company enrolled 38 providers and saw approximately $1.3 million in provider revenue, compared to 32 providers and approximately $0.9 million for the first quarter of 2022.

3. The company saw $2.3 million in gross profit, compared to $2.6 million for the first quarter of 2022. The company attributed the decrease to higher costs associated with increased provider training as well as the sale and leasing of its home sleep test rings.

4. Vivos’ gross margin was 61 percent during the first quarter of 2023, compared to 70 percent for the first quarter of 2022

5. The company’s cost-cutting initiatives resulted in a 20 percent drop in operating expenses compared to the first quarter of 2022.

Advertisement

Next Up in Dental Technology

  • Here are three companies that have earned FDA clearances for dental technology in 2025: 1. Dental technology company Perimetrics received…

  • Here are six statistics and trends showing how dental technology is evolving: 1. Venture capital funding hit more than $145…

  • Here are three notable acquisitions of dental technology companies that have taken place in recent months: 1. Dental 3D printing…

Advertisement

Comments are closed.